Northstar Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$913K Hold
993
0.13% 80
2025
Q4
$1.07M Hold
993
0.15% 73
2025
Q3
$758K Sell
993
-74
-7% -$55.1K 0.11% 84
2025
Q2
$832K Sell
1,067
-3
-0.3% -$2.33K 0.13% 77
2025
Q1
$884K Buy
1,070
+17
+2% +$14.1K 0.14% 71
2024
Q4
$813K Sell
1,053
-12
-1% -$9.94K 0.14% 76
2024
Q3
$944K Sell
1,065
-20
-2% -$18K 0.16% 68
2024
Q2
$982K Hold
1,085
0.19% 64
2024
Q1
$844K Hold
1,085
0.17% 72
2023
Q4
$632K Hold
1,085
0.14% 77
2023
Q3
$583K Sell
1,085
-75
-6% -$38.6K 0.14% 81
2023
Q2
$544K Sell
1,160
-100
-8% -$41.9K 0.13% 84
2023
Q1
$433K Buy
1,260
+110
+10% +$37.1K 0.11% 92
2022
Q4
$421K Hold
1,150
0.12% 95
2022
Q3
$372K Hold
1,150
0.11% 99
2022
Q2
$373K Hold
1,150
0.11% 102
2022
Q1
$329K Hold
1,150
0.08% 120
2021
Q4
$317K Hold
1,150
0.08% 127
2021
Q3
$265K Hold
1,150
0.07% 133
2021
Q2
$264K Buy
+1,150
New +$231K 0.07% 132

Other funds holding LLY

Northstar Group's LLY Position: Q1 2026 in Review

Northstar Group held its Eli Lilly (LLY) position steady in Q1 2026 at 993 shares worth $913K. The position accounts for 0.13% of the portfolio, ranked #80.

Northstar Group first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.07M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Northstar Group held 993 shares of Eli Lilly worth $913K as of Q1 2026.
  • Northstar Group left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.13% of Northstar Group's portfolio in Q1 2026, its #80 holding.
  • Northstar Group first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
  • Northstar Group's Eli Lilly position peaked at $1.07M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Northstar Group's 13F filing for Q1 2026, filed 28 Apr 2026.